Sponsor or institution
Clinical trials and research at Cincinnati Eye Institute, Southwest Ohio
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Cincinnati Eye Institute, Southwest Ohio that are recruiting, in United States. By phase: Phase 2 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Faricimab for CNV in Presumed Ocular Histoplasmosis Syndrome
This study tests whether Faricimab can safely and effectively treat choroidal neovascularization linked to presumed ocular histoplasmosis in adults over a 52-week period.
-
Preventing vision loss after retinal detachment surgery with methotrexate
This study is testing if a medication called methotrexate can help prevent vision loss from complications after retinal detachment surgery in adults.
Quick answers
How many clinical trials run by Cincinnati Eye Institute, Southwest Ohio are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.